![tabulo rosa tabulo rosa](https://image.slidesharecdn.com/tabuladomodulos-140513165526-phpapp01/95/tabulado-modulos-38-638.jpg)
Bed Bath & Beyond Meat: Is BYND the Next Big Short Squeeze?.Three Industrial Stocks That Can Weather a Stormy Recession.Should You Buy These Copper Stocks Ahead Of Monster Demand?.MarketBeat Podcast: Fantasy Football Strategy With Your Stock Portfolio.
TABULO ROSA FREE
Get a free copy of the research report on Tabula Rasa HealthCare (TRHC).It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. 7.25% of the stock is owned by company insiders. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Following the completion of the transaction, the insider now owns 6,521,578 shares in the company, valued at $27,912,353.84. The shares were bought at an average cost of $4.28 per share, for a total transaction of $253,641.36. In other news, major shareholder Indaba Capital Management, L.P bought 59,262 shares of the firm’s stock in a transaction on Monday, July 25th. Based on data from, the company currently has an average rating of “Hold” and a consensus target price of $11.21. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. Finally, SVB Leerink boosted their target price on Tabula Rasa HealthCare from $4.00 to $5.50 and gave the company a “market perform” rating in a report on Monday, August 8th. Stifel Nicolaus dropped their target price on Tabula Rasa HealthCare to $5.00 and set a “hold” rating on the stock in a report on Wednesday, June 22nd. Piper Sandler boosted their target price on Tabula Rasa HealthCare to $6.00 and gave the company a “neutral” rating in a report on Thursday, August 18th. lowered Tabula Rasa HealthCare from a “hold” rating to a “sell” rating in a research report on Friday, May 13th. Several research analysts have commented on TRHC shares. 89.38% of the stock is owned by institutional investors and hedge funds. Lombard Odier Asset Management Switzerland SA now owns 394,559 shares of the company’s stock worth $5,918,000 after purchasing an additional 33,372 shares during the last quarter. Finally, Lombard Odier Asset Management Switzerland SA lifted its stake in Tabula Rasa HealthCare by 9.2% during the fourth quarter.
![tabulo rosa tabulo rosa](https://es.web.img3.acsta.net/pictures/17/06/07/10/53/182064.jpg)
purchased a new stake in Tabula Rasa HealthCare during the fourth quarter worth approximately $638,000. Forest Hill Capital LLC purchased a new stake in Tabula Rasa HealthCare during the fourth quarter worth approximately $1,050,000. Walleye Capital LLC purchased a new position in shares of Tabula Rasa HealthCare in the 4th quarter valued at about $2,274,000. First Trust Advisors LP now owns 3,467,436 shares of the company’s stock worth $52,012,000 after acquiring an additional 2,119,168 shares during the last quarter. First Trust Advisors LP increased its stake in shares of Tabula Rasa HealthCare by 157.2% in the 4th quarter. New York State Common Retirement Fund’s holdings in Tabula Rasa HealthCare were worth $44,000 as of its most recent SEC filing.Ī number of other hedge funds and other institutional investors have also modified their holdings of TRHC. The fund owned 7,720 shares of the company’s stock after selling 8,358 shares during the quarter. ( NASDAQ:TRHC – Get Rating) by 52.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission.
![tabulo rosa tabulo rosa](https://www.modelaje.com/images/photographer/TabulaRasa/TabulaRasaPhotography%20(496).jpg)
New York State Common Retirement Fund cut its stake in Tabula Rasa HealthCare, Inc.